LY 219057 is a potent, competitive, and specific CCK receptor antagonist on the exocrine pancreas.
Uses
LY219057 is a potent antagonist of cholecystokinin octapeptide (CCK-8), with the ID50 of 287.5 nM[1][2].
References
[1] T Akiyama, et al. Characterization of a new diphenylpyrazolidinone cholecystokinin antagonist in vitro isolated rat pancreatic acini. Int J Pancreatol. 1993 Oct;14(2):167-73. DOI:10.1007/BF02786123
